PAS — Pascal Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Pascal Biosciences, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.24 | -3.41 | -1.24 | -1.09 | -0.48 |
| Depreciation | |||||
| Non-Cash Items | 1.14 | 0.165 | -0.031 | 0.297 | 0.072 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.047 | -0.033 | 0.393 | 0.161 | 0.252 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.95 | -3.27 | -0.863 | -0.615 | -0.148 |
| Capital Expenditures | -0.007 | -0.002 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.009 |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.007 | -0.002 | 0 | — | 0.009 |
| Financing Cash Flow Items | — | — | — | -0.046 | -0.02 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.49 | 0 | 0.471 | 0.624 | 0.155 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.53 | -3.27 | -0.392 | 0.009 | 0.016 |